China shows off Covid-19 vaccines for the first time
China has put its homegrown Covid vaccines on display for first time, as the nation where the infection was found looks to shape the narrative surrounding the pandemic.
- China has been trying to repurpose the story of COVID-19.
- Chinese organization is ready to produce 300 million doses per year.
High expectations hold tight the little vials of liquid on show at a Beijing Trade Fair this week - vaccine competitors produced by Chinese organizations Sinovac Biotech and Sinopharm.
Neither has hit the market yet however the producers trust they will be approved after most important stage 3 trials as early as year-end.
A Sinovac agent revealed to AFP his firm has just “finished the construction of a vaccine factory” ready to produce 300 million dosages per year.
On Monday, individuals at the trade fair crowded around booths showing the potential game-changing vaccine.
China, which is facing a storm of foreign criticism over its initial treatment of the pandemic, has been trying to repurpose the story of COVID-19.
State media and authorities are currently emphasising the recovery of Wuhan, the central Chinese city where the dangerous micro-organism surfaced, as an example of overcoming in the battle against the infection.
They are also promoting progress on domestic vaccines as an indication of Chinese administration and versatility despite an extraordinary healthy threat that has pummeled the global economy.
China shows off Covid-19 vaccines for first time https://t.co/zK5I18dmt2 via @YahooNews
— News & Quotes (@LesVDavis) September 7, 2020
In May, President Xi Jinping vowed to make any potential vaccine created by China a “global public good”.
The possible vaccines on display are among about 10 worldwide to enter stage 3 trials, commonly the last step in front of administrative approval, as countries race to hit out the virus and reboot battered economies.
Sinopharm said it foresees the antibodies from its poke to last somewhere in the range of one and three years - despite the fact that the final result may be known after the trials.
China's nationalistic newspaper Global Times detailed a month ago that “the cost of the vaccines won't be high”.
Each two dosages should cost under 1,000 yuan ($146), the report stated, refering to Sinopharm's chairman, who told media he has just been injected with one of the candidate vaccines.
